These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 18772338)
1. Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling. Anderson CR; Hastings NE; Blackman BR; Price RJ Am J Pathol; 2008 Oct; 173(4):1220-8. PubMed ID: 18772338 [TBL] [Abstract][Full Text] [Related]
2. Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo. Bongrazio M; Da Silva-Azevedo L; Bergmann EC; Baum O; Hinz B; Pries AR; Zakrzewicz A Int J Immunopathol Pharmacol; 2006; 19(1):35-48. PubMed ID: 16569344 [TBL] [Abstract][Full Text] [Related]
3. Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase. Kazerounian S; Duquette M; Reyes MA; Lawler JT; Song K; Perruzzi C; Primo L; Khosravi-Far R; Bussolino F; Rabinovitz I; Lawler J Blood; 2011 Apr; 117(17):4658-66. PubMed ID: 21378271 [TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells. Chu LY; Ramakrishnan DP; Silverstein RL Blood; 2013 Sep; 122(10):1822-32. PubMed ID: 23896411 [TBL] [Abstract][Full Text] [Related]
5. CD36-TSP-HRGP interactions in the regulation of angiogenesis. Silverstein RL; Febbraio M Curr Pharm Des; 2007; 13(35):3559-67. PubMed ID: 18220792 [TBL] [Abstract][Full Text] [Related]
6. Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. Cursiefen C; Maruyama K; Bock F; Saban D; Sadrai Z; Lawler J; Dana R; Masli S J Exp Med; 2011 May; 208(5):1083-92. PubMed ID: 21536744 [TBL] [Abstract][Full Text] [Related]
7. Identification of CD36 molecular features required for its in vitro angiostatic activity. Primo L; Ferrandi C; Roca C; Marchiò S; di Blasio L; Alessio M; Bussolino F FASEB J; 2005 Oct; 19(12):1713-5. PubMed ID: 16037098 [TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway. Ren B; Hale J; Srikanthan S; Silverstein RL Blood; 2011 Jun; 117(22):6036-45. PubMed ID: 21441463 [TBL] [Abstract][Full Text] [Related]
10. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo. Koch M; Hussein F; Woeste A; Gründker C; Frontzek K; Emons G; Hawighorst T Breast Cancer Res Treat; 2011 Jul; 128(2):337-46. PubMed ID: 20714802 [TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 inhibits in vitro megakaryocytopoiesis via CD36. Yang M; Li K; Ng MH; Yuen PM; Fok TF; Li CK; Hogg PJ; Chong BH Thromb Res; 2003 Jan; 109(1):47-54. PubMed ID: 12679131 [TBL] [Abstract][Full Text] [Related]
12. Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth. Hale JS; Li M; Sinyuk M; Jahnen-Dechent W; Lathia JD; Silverstein RL PLoS One; 2012; 7(7):e40033. PubMed ID: 22808089 [TBL] [Abstract][Full Text] [Related]
13. The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway. Bussolati B; Assenzio B; Deregibus MC; Camussi G J Mol Med (Berl); 2006 Oct; 84(10):852-63. PubMed ID: 16924472 [TBL] [Abstract][Full Text] [Related]
14. c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1. Jiménez B; Volpert OV; Reiher F; Chang L; Muñoz A; Karin M; Bouck N Oncogene; 2001 Jun; 20(26):3443-8. PubMed ID: 11423995 [TBL] [Abstract][Full Text] [Related]